BPC-157 is usually the starting point because of its well-documented safety profile and targeted tissue repair properties
(2008) and Zhao et al
Garca-VillalbaRSelmaMVEspnJCToms-BarbernFA
The effect of estrogen replacement therapy on Alzheimers disease and Parkinsons disease in postmenopausal women: a meta-analysis
Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK Lymphadenopathy is not listed in the Summary of Product Characteristics or reported in SURPASS or SURMOUNT clinical trials Common Mounjaro side effects are predominantly gastrointestinal, including nausea, vomiting, diarrhoea, and reduced appetite Lymph node swelling during treatment may result from infections, vaccinations, local inflammation, or other unrelated conditions Persistent, enlarging, or hard lymph nodes require GP evaluation to exclude serious underlying causes including malignancy Report any suspected adverse effects through the MHRA Yellow Card Scheme for ongoing pharmacovigilance monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus
Cellular energy & anti-aging support Physician-prescribed NAD+ injections to support cellular energy production, DNA repair, and healthy aging
